I reported previously (see here) on the AJOVY fremanezumab migraine treatment from Israel’s Teva. The US FDA has just given approval for AJOVY – the only anti-CGRP treatment for the prevention of migraine. About 40% of migraine sufferers may be candidates for this treatment.
US approval for migraine treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.
Is this treatment available in Australia? My daughter has suffered from migraine headaches for many years without finding a cure.
I have two friends who suffer from this. Where can we get ti in the USA?